financetom
Business
financetom
/
Business
/
MacDonald Mines Withdraws Prior Announced Scadding Gold Project Assays Pending Further Review; Reports Note Similar Problems at Red Pine Exploration
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MacDonald Mines Withdraws Prior Announced Scadding Gold Project Assays Pending Further Review; Reports Note Similar Problems at Red Pine Exploration
May 28, 2024 12:18 PM

02:57 PM EDT, 05/28/2024 (MT Newswires) -- MacDonald Mines Exploration Ltd. ( MCDMF ) is trading slightly lower and at 52 week lows Tuesday as market watchers pick up on news that the company issued late last Friday night.

According to the company it has "discovered inconsistencies" in certain assay results from the Scadding gold prospect that were previously publicly announced by way of press releases and which may also have been disclosed or used in certain other disclosure documents, such as the National Instrument 43-101 technical report on the Scadding gold project dated Oct.18, 2019. Accordingly, the company has withdrawn all its previously announced assay results for the Scadding gold project and advises that such results and the disclosure that such results are based on should not be relied upon.

The company said it is conducting a detailed review and comparison of the assay results from the Scadding gold project with the company's disclosure documents in order to identify and quantify the extent of any incongruities.

These inconsistencies, it said, are limited to the Scadding gold project which is not a flagship project for the company nor is there a resource of any kind associated with it. The Glade and Alwyn properties are unaffected, it added.

Meanwhile, The Globe and Mail newspaper noted today that MacDonald Mines is the second junior Canadian exploration company this month to blindside investors with assay problems.

The Globe noted Toronto-based Red Pine Exploration Inc. ( RDEXF ) a few weeks ago said it found inconsistencies in some of its drilling results at its Wawa gold project in Ontario, and accused its former CEO of manipulating hundreds of gold assays. The Globe also noted Red Pine stumbled upon the assay inconsistencies by accident after one of its geologists discovered an anomaly in its drill results.

The Globe noted MacDonald Mines has not disclosed how it discovered the problems with its assays, or who it believes is responsible. Mike England, the interim CEO of MacDonald Mines did not respond to a request for comment.

Price: 0.03, Change: -0.01, Percent Change: -14.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alibaba groceries arm Freshippo CEO to step down
Alibaba groceries arm Freshippo CEO to step down
Mar 18, 2024
BEIJING, March 18 (Reuters) - Freshippo, the groceries arm of e-commerce giant Alibaba Group ( BABA ), told staff that its CEO Hou Yi would retire, according to an internal letter seen by Reuters on Monday. Current CFO Yan Xiaolei will take on the CEO role, while Hou will continue as consultant to the company, the letter said. ...
China's military, state media slam U.S. after Reuters report on SpaceX spy satellites
China's military, state media slam U.S. after Reuters report on SpaceX spy satellites
Mar 18, 2024
BEIJING, March 18 (Reuters) - Chinese military and state-run media on Sunday accused the United States of threatening global security, days after a Reuters report which found Elon Musk's SpaceX was building hundreds of spy satellites for a U.S. intelligence agency. SpaceX's Starshield unit is developing the satellite network under a classified $1.8 billion contract with the National Reconnaissance Office...
Fennec Pharmaceuticals Signs Exclusive Licensing Deal With Norgine
Fennec Pharmaceuticals Signs Exclusive Licensing Deal With Norgine
Mar 18, 2024
05:32 AM EDT, 03/18/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) and Norgine said Sunday that they have signed an exclusive licensing agreement to commercialize Pedmarqsi, which is intended for the prevention of hearing loss induced by cisplatin chemotherapy in patients one month to less than 18 years old with localized, non-metastatic solid tumors. Under the agreement, Norgine will...
Joann Launches Voluntary Chapter 11 Cases to Cut Debt, Emerge as Private Company
Joann Launches Voluntary Chapter 11 Cases to Cut Debt, Emerge as Private Company
Mar 18, 2024
05:14 AM EDT, 03/18/2024 (MT Newswires) -- Joann ( JOAN ) said Monday it has launched voluntary prepackaged Chapter 11 cases in the US with the aim of completing the process as soon as late April and emerging as a private company. The specialty retailer said it has agreed with most of its financial stakeholders and additional financiers for about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved